Literature DB >> 11549755

Loss of purinergic P2X(3) and P2X(5) receptor innervation in human detrusor from adults with urge incontinence.

K H Moore1, F R Ray, J A Barden.   

Abstract

Activation of purinergic P2X receptors associated with the parasympathetic nerves that supply the human bladder smooth muscle (detrusor) is implicated in control of detrusor contractility. The relative abundance of all seven subtypes colocalized with synaptic vesicles on parasympathetic nerves was examined in specimens from normal adult bladder, infants, and in adults with overactive detrusor contractility and a diagnosis of idiopathic detrusor instability (IDI) to determine whether receptor distribution varied with age or in patients with incontinence. Alteration in control of detrusor innervation was examined with P2X subtype-specific antibodies and an antibody against synaptic vesicles, using immunofluorescence and confocal microscopy. Detrusor samples were taken from: controls, at cystectomy for cancer or cystoscopic biopsy for hematuria (n = 22; age 33-88), child bladder, at surgical correction of vesico-ureteric reflux (n = 21; age 4 months to 2 years), and adults with detrusor instability at cystoscopy-cystodistension (n = 18; age 30-81). Adult specimens contained muscle with large varicosities (1.2 microm) along parasympathetic nerves with colocalized patches of all P2X(1-7) subtypes. Infant bladder revealed little evidence of P2X at age <9 months but approached adult levels at 2 years. Detrusor from IDI patients revealed selective absence of P2X(3) and P2X(5) beneath all the varicosities. This specific lack of P2X(3) and P2X(5) may impair control of detrusor contractility and contribute to the pathophysiology of urge incontinence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549755      PMCID: PMC6763010     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  12 in total

1.  ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells.

Authors:  Edward C Y Wang; Jey-Myung Lee; Wily G Ruiz; Elena M Balestreire; Maximilian von Bodungen; Stacey Barrick; Debra A Cockayne; Lori A Birder; Gerard Apodaca
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

2.  Expression and function of rat urothelial P2Y receptors.

Authors:  Bikramjit Chopra; Joel Gever; Stacey R Barrick; Ann T Hanna-Mitchell; Jonathan M Beckel; Anthony P D W Ford; Lori A Birder
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-23

Review 3.  The puzzle of overactive bladder: controversies, inconsistencies, and insights.

Authors:  Roger R Dmochowski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-06-27

Review 4.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

Review 5.  [Changes in muscarinic receptors of the aging bladder].

Authors:  K-E Andersson; A Schröder
Journal:  Urologe A       Date:  2004-05       Impact factor: 0.639

Review 6.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

7.  Extracellular UDP enhances P2X-mediated bladder smooth muscle contractility via P2Y(6) activation of the phospholipase C/inositol trisphosphate pathway.

Authors:  Weiqun Yu; Xiaofeng Sun; Simon C Robson; Warren G Hill
Journal:  FASEB J       Date:  2013-01-29       Impact factor: 5.191

8.  Expression and distribution of ectonucleotidases in mouse urinary bladder.

Authors:  Weiqun Yu; Simon C Robson; Warren G Hill
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

9.  Purinergic signalling in the urinary bladder - When function becomes dysfunction.

Authors:  Christopher H Fry; Karen D McCloskey
Journal:  Auton Neurosci       Date:  2021-07-17       Impact factor: 2.355

10.  Overactive bladder syndrome pharmacotherapy: future treatment options.

Authors:  Andrzej Wróbel
Journal:  Prz Menopauzalny       Date:  2015-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.